Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
LinkoCare Life Sciences AB
AB
Active
Org 5569478398
Frösundaleden 2 B, 169 75
Solna
Manufacture of medical and dental instruments and supplies
·
NACE 3250
Est. 2013 · 12 years old
5-9 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of medical and dental instruments and supplies
/
LinkoCare Life Sciences AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
2M
2M
1M
1M
0M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 2M
2M
2022
2023: 0M (-100% vs 2022)
0M
-100%
2023
2024: 1M
1M
2024
EBITDA
SEK millions
0M
-2M
-5M
-7M
-10M
2020: -3M
-3M
2020
2021: -3M (0% vs 2020)
-3M
0%
2021
2022: -1M (+67% vs 2021)
-1M
+67%
2022
2023: -4M (-300% vs 2022)
-4M
-300%
2023
2024: -8M (-100% vs 2023)
-8M
-100%
2024
Income statement
SEK thousands
Item
2024
2023
2022
2021
2020
Revenue
540
282
1 574
0
10
Staff expenses
—
—
—
—
—
EBITDA
−8 173
−4 139
−1 455
−3 001
−2 825
Depreciation & amort.
−480
−68
−149
−205
−220
EBIT
−8 653
−4 207
−1 604
−3 206
−3 045
Net financials
39
−18
−49
−13
−55
Profit before tax
−8 614
−4 225
−1 652
−3 220
−3 100
Tax
−0
−0
−0
−0
−0
Net profit
−8 614
−4 225
−1 652
−3 220
−3 100
Balance sheet
SEK thousands
Item
2024
2023
2022
2021
2020
Total assets
11 351
1 617
2 276
785
905
Equity
7 541
910
1 896
408
552
Long-term debt
0
0
0
0
0
Short-term debt
3 810
706
380
377
354
Total debt
3 810
706
380
377
354
Financial ratios
5-year trend
EBITDA margin
<−999 %
This company
15,8 %
Market median
This company
Market median
>999% below market
2020
2024
Equity ratio
66,4 %
This company
38,2 %
Market median
This company
Market median
74% above market
2020
2024
Return on equity
−114,2 %
This company
18,4 %
Market median
This company
Market median
721% below market
2020
2024
Net profit margin
<−999 %
This company
8,1 %
Market median
This company
Market median
>999% below market
2020
2024
Asset turnover
0,05×
This company
1,12×
Market median
This company
Market median
96% below market
2020
2024
Debt / equity
0,51×
This company
0,62×
Market median
This company
Market median
18% below market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on LinkoCare Life Sciences AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
